Voice-based conversational artificial intelligence may improve insulin management for diabetes

1. This randomized clinical trial demonstrated that compared with the standard of care, voice-based conversational artificial intelligence (VBAI) improved time to optimal insulin dosing, insulin adherence, glycemic control, and diabetes-related distress among adults with type 2 diabetes. Evidence Rating Level: 1 (Excellent) Study Rundown:  Type 2 diabetes affects 33 million US adults, with nearly a […]

The post Voice-based conversational artificial intelligence may improve insulin management for diabetes first appeared on 2 Minute Medicine.